Nuvation Bio (NUVB) Non Operating Investment Income: 2023-2025

Historic Non Operating Investment Income for Nuvation Bio (NUVB) over the last 2 years, with Jun 2025 value amounting to -$1,000.

  • Nuvation Bio's Non Operating Investment Income rose 85.71% to -$1,000 in Q2 2025 from the same period last year, while for Jun 2025 it was -$4,000, marking a year-over-year decrease of 108.00%. This contributed to the annual value of -$12,000 for FY2024, which is 91.37% up from last year.
  • Nuvation Bio's Non Operating Investment Income amounted to -$1,000 in Q2 2025, which was down 133.33% from $3,000 recorded in Q1 2025.
  • Nuvation Bio's 5-year Non Operating Investment Income high stood at $44,000 for Q4 2023, and its period low was -$96,000 during Q2 2023.
  • In the last 3 years, Nuvation Bio's Non Operating Investment Income had a median value of $1,000 in 2024 and averaged -$5,556.
  • In the last 5 years, Nuvation Bio's Non Operating Investment Income slumped by 191.67% in 2024 and then surged by 200.00% in 2025.
  • Over the past 3 years, Nuvation Bio's Non Operating Investment Income (Quarterly) stood at $44,000 in 2023, then slumped by 88.64% to $5,000 in 2024, then spiked by 85.71% to -$1,000 in 2025.
  • Its last three reported values are -$1,000 in Q2 2025, $3,000 for Q1 2025, and $5,000 during Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Summit Therapeutics Inc. 1,387.71B 1,387.50B - -
2 BeOne Medicines Ltd. 458.68B 457.16B 1.15B -
3 Vertex Pharmaceuticals Inc / Ma 102.37B 99.35B - -
4 Benitec Biopharma Inc. 65.38B 65.31B - -
5 Regeneron Pharmaceuticals, Inc. 60.67B 60.28B - -
6 Alnylam Pharmaceuticals, Inc. 60.53B 62.66B - -
7 Argenx Se 45.96B 50.00B - -
8 INSMED Inc 26.50B 27.40B - -
9 BioNTech SE 25.15B 17.24B - -
10 Nuvation Bio Inc. 1.42B 1.38B 2.26M -1,000

Historic Data

Download Data 🔒
Date Value
Jun 30, 2025 -1,000
Jun 30, 2025 -1,000
Mar 31, 2025 3,000
Mar 31, 2025 3,000
Dec 31, 2024 5,000
Dec 31, 2024 5,000
Sep 30, 2024 -11,000
Sep 30, 2024 -11,000
Jun 30, 2024 -7,000
Jun 30, 2024 -7,000
Mar 31, 2024 1,000
Mar 31, 2024 1,000